A Study of Ad26.COV2.S Administered as Booster Vaccination in Adults Who Have Previously Received Primary Vaccination With Ad26.COV2.S or BNT162b2

NCT04999111 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1541

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronavirus Disease

Interventions

BIOLOGICAL: Ad26.COV2.S

Sponsor

Janssen Vaccines & Prevention B.V.